UMIN-CTR History

Name：　　UMIN ID：

Unique ID issued by UMIN	UMIN000031912
Receipt number	R000036441
Scientific Title	Phase 1 study of YM155, novel selective survivin suppressant in combination with elrotinib in patients with EGFR-mutant advanced non-small-cell lung cancer
Date of disclosure of the study information	2018/03/27
Last modified on	2018/03/26 23:38:32

---